The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles
- PMID: 15752743
- DOI: 10.1016/j.bbrc.2005.02.057
The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles
Abstract
The main function of Vif is to limit the antiviral activity of APOBEC3G by counteracting its packaging into HIV-1 virions. In this work, we examine the possible functional interactions between Vif, APOBEC3G, and two Src family tyrosine kinases, Fyn and Hck, present in T lymphocytes and in monocyte-macrophages, respectively. By GST pull-down, we show that the SH3 domains of Fyn and Hck, and the corresponding full-length proteins bind Vif of HIV-1. One consequence of this interaction is a reduction in their catalytic activity. Interestingly, we also observed that APOBEC3G can be phosphorylated on tyrosine in the presence of Fyn or Hck, suggesting that both kinases may regulate APOBEC3G function. Accordingly, we demonstrate that in the presence of Fyn or Hck and in the absence of Vif, the overall level of APOBEC3G incorporated into HIV-1 particles is decreased, whereas the level of encapsidation of its phosphorylated form is significantly enhanced.
Similar articles
-
The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.J Biol Chem. 2001 May 18;276(20):16885-93. doi: 10.1074/jbc.M009076200. Epub 2001 Feb 27. J Biol Chem. 2001. PMID: 11278465
-
Functional domains of APOBEC3G required for antiviral activity.J Cell Biochem. 2004 Jun 1;92(3):560-72. doi: 10.1002/jcb.20082. J Cell Biochem. 2004. PMID: 15156567
-
The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.J Virol. 2003 Nov;77(21):11398-407. doi: 10.1128/jvi.77.21.11398-11407.2003. J Virol. 2003. PMID: 14557625 Free PMC article.
-
New insights into the role of Vif in HIV-1 replication.AIDS Rev. 2004 Jan-Mar;6(1):34-9. AIDS Rev. 2004. PMID: 15168739 Review.
-
Cellular interactions of virion infectivity factor (Vif) as potential therapeutic targets: APOBEC3G and more?Curr Drug Targets. 2006 Dec;7(12):1583-93. doi: 10.2174/138945006779025356. Curr Drug Targets. 2006. PMID: 17168833 Review.
Cited by
-
Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target?Adv Virol. 2010;2010:649315. doi: 10.1155/2010/649315. Epub 2010 Sep 21. Adv Virol. 2010. PMID: 22347227 Free PMC article.
-
Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity.Retrovirology. 2013 Jul 17;10:73. doi: 10.1186/1742-4690-10-73. Retrovirology. 2013. PMID: 23866860 Free PMC article.
-
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.J Virol. 2007 Aug;81(15):8201-10. doi: 10.1128/JVI.00395-07. Epub 2007 May 23. J Virol. 2007. PMID: 17522216 Free PMC article.
-
HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.J Neuroimmune Pharmacol. 2011 Jun;6(2):296-307. doi: 10.1007/s11481-011-9258-7. Epub 2011 Jan 29. J Neuroimmune Pharmacol. 2011. PMID: 21279453
-
Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.RNA Biol. 2014;11(7):906-20. doi: 10.4161/rna.29546. Epub 2014 Jul 22. RNA Biol. 2014. PMID: 25144404 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous